CP
INDV icon

CenterBook Partners’s Indivior Pharmaceuticals INDV Stock Holding History

CenterBook Partners’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Sell
48,502
-19,577
-29% -$647K 0.08% 285
2025
Q4 		$2.44M Sell
68,079
-41,380
-38% -$1.26M 0.12% 230
2025
Q3 		$2.64M Sell
109,459
-12,213
-10% -$256K 0.13% 218
2025
Q2 		$1.79M Sell
121,672
-127,754
-51% -$1.49M 0.1% 240
2025
Q1 		$2.38M Sell
249,426
-898,415
-78% -$9.45M 0.15% 174
2024
Q4 		$14.3M Buy
1,147,841
+589,158
+105% +$6.06M 0.85% 21
2024
Q3 		$5.45M Buy
+558,683
New +$6.54M 0.33% 86

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CenterBook Partners's INDV Position: Q1 2026 in Review

CenterBook Partners reduced its Indivior Pharmaceuticals (INDV) stake by 29% in Q1 2026, selling an estimated $647K and leaving 48,502 shares worth $1.48M. The position accounts for 0.08% of the portfolio, ranked #285.

CenterBook Partners first reported a position in INDV in Q3 2024 and has held it in 7 quarters since. The position peaked at $14.3M in Q4 2024. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • CenterBook Partners held 48,502 shares of Indivior Pharmaceuticals worth $1.48M as of Q1 2026.
  • CenterBook Partners sold 19,577 Indivior Pharmaceuticals shares in Q1 2026, an estimated $647K.
  • Indivior Pharmaceuticals made up 0.08% of CenterBook Partners's portfolio in Q1 2026, its #285 holding.
  • CenterBook Partners first reported a position in Indivior Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • CenterBook Partners's Indivior Pharmaceuticals position peaked at $14.3M in Q4 2024.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.